Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Since the first transcatheter aortic valve implantation in 2002, catheter-based cardiac procedures have increased significantly. This review provides an overview of CE approved devices, updated guidelines, and the key clinical findings for TAVR as well as for AV Valve interventions. Recent studies compare balloon-expanding and self-expanding valves, highlighting differences in prosthesis mismatch and paravalvular leaks. Long-term trials confirm TAVR's efficacy, especially in low-risk patients. Challenges include paravalvular regurgitation, vascular complications, and coronary obstruction, with innovations like the BASILICA procedure addressing risks. Local anesthesia in TAVR shows benefits over general anesthesia. As TAVR expands to younger patients, optimizing management pathways and addressing complications remain critical for improved outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.anclin.2025.03.001 | DOI Listing |